EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study

A Cigliola, B A Maiorano, F Rossari, V Tateo, C Mercinelli, N Dizman, M Colecchia, F De Cobelli, A Larcher, G Rosiello, A Briganti, F Montorsi und 5 weitere

ESMO Open · 2026-05 · 11 (5) · 106901

DOI: 10.1016/j.esmoop.2026.106901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESMO Open, 2026-05. Verfasst von A Cigliola und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: cig…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsImmune Checkpoint InhibitorsHumansRetrospective StudiesFemaleMaleMiddle AgedAgedAntibodies, Monoclonal, HumanizedProgression-Free SurvivalAnilidesTreatment Outcome

Stichwörter der Autor:innen

clear-cell renal cell carcinomaimmune-checkpoint inhibitorsimmunotherapy rechallengereal-world data

Substanzen

Immune Checkpoint InhibitorsAntibodies, Monoclonal, HumanizedAnilides

Autor:innen und Institutionen

  • Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: cigliola.antonio@hsr.it.
  • Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
  • The University of Texas MD Anderson Cancer Center, Houston, USA; City of Hope Comprehensive Cancer Center, Duarte, USA.
  • Vita-Salute San Raffaele University, Milan, Italy; Department of Pathology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy; Department of Radiology, IRCCS San Raffaele Hospital, Milan, Italy.

Zitieren

APA

Cigliola, A., Maiorano, B. A., Rossari, F., Tateo, V., Mercinelli, C., Dizman, N., Colecchia, M., De Cobelli, F., Larcher, A., Rosiello, G., Briganti, A., Montorsi, F., Capitanio, U., Spiess, P. E., Agarwal, N., Pal, S. K., & Necchi, A. (2026). Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study. ESMO Open, 11(5), 106901. https://doi.org/10.1016/j.esmoop.2026.106901

Vancouver

Cigliola A, Maiorano BA, Rossari F, Tateo V, Mercinelli C, Dizman N, et al. Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study. ESMO Open. 2026;11(5):106901. doi:10.1016/j.esmoop.2026.106901

BibTeX
@article{Cigliola2026,
  author = {Cigliola, A and Maiorano, B A and Rossari, F and Tateo, V and Mercinelli, C and Dizman, N and Colecchia, M and De Cobelli, F and Larcher, A and Rosiello, G and Briganti, A and Montorsi, F and Capitanio, U and Spiess, P E and Agarwal, N and Pal, S K and Necchi, A},
  title = {Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study},
  journal = {ESMO Open},
  year = {2026},
  volume = {11},
  number = {5},
  pages = {106901},
  doi = {10.1016/j.esmoop.2026.106901}
}
Kostenlos starten →